The discovery of the Andes strain of hantavirus among people linked to the MV Hondius cruise has forced an international health response. On May 6, 2026, health agencies and the World Health Organization confirmed that samples taken from affected passengers match a variant known to have caused rare instances of human-to-human transmission. Several evacuees have been flown to specialized hospitals, one confirmed case has been treated after returning to Switzerland, and multiple fatalities connected to the voyage have been reported.
Officials stress that the overall risk to the general public remains low, but the situation has required coordinated logistics: isolation of those still on board, targeted medical transfers, and extensive contact tracing. The ship remained anchored near Cape Verde while authorities arranged a route to the Canary Islands for disembarkation and clinical assessment. Regional leaders and national governments have negotiated responsibilities over reception and quarantine arrangements as health teams work to limit secondary spread.
What the testing and case count reveal
Laboratories collaborating with national health bodies have identified the Andes strain in more than one passenger, a development that changes the focus of the response because this strain is the only hantavirus lineage with documented person-to-person transmission under close-contact conditions. Health authorities have reported a mix of confirmed and suspected infections among those who sailed on the MV Hondius, with three fatalities linked to the outbreak. As of the latest briefings, some patients have been evacuated to facilities in South Africa, the Netherlands and elsewhere for specialized care.
Where infections were confirmed and how samples were processed
Testing was carried out in national reference laboratories working with international partners to genotype viral samples. The Andes strain, typically associated with South America, was detected in evacuees whose clinical onset followed the ship’s departure from Argentina. A case that developed after a passenger returned home to Switzerland was also confirmed in hospital. Those laboratory results have informed targeted interventions, including the isolation of symptomatic people and testing of exposed health staff and transport workers.
Transmission risk and public health measures
Hantaviruses generally transmit from infected rodents through excreta, but the Andes strain has an unusual profile because of rare documented instances of direct person-to-person spread, usually between intimate or prolonged contacts. Public health agencies emphasize that transmission between strangers or casual contacts remains unlikely. Authorities are combining cabin isolation, surface disinfection, and controlled transfers to reduce risk while monitoring for symptoms over what experts note can be a long incubation period of up to 45 days in some reports.
Contact tracing, evacuations and reception plans
Teams have prioritized tracing those who had close contact with confirmed patients, including medical personnel, ambulance crews, port staff and fellow passengers. In one reported update, investigators had traced a substantial portion of identified contacts and continued efforts to reach the remainder. Several patients were medically evacuated to Europe and Africa; national authorities arranged specialized transport and hospital admission for assessment and treatment. The Canary Islands were agreed as a likely reception point, though local leaders raised concerns and asked for guarantees before disembarkation.
Why this strain matters and what to expect next
The presence of a strain with documented close-contact spread changes the investigative priorities: confirmatory testing, targeted quarantine of high-risk contacts, and transparent coordination among countries where passengers will return. Clinical management focuses on respiratory support where necessary, since hantaviruses can cause severe cardiopulmonary illness with a substantial fatality rate in some outbreaks. For now, international bodies continue to advise that the immediate risk to the public is low, while urging vigilance, rapid testing, and follow-up for anyone who had sustained exposure to infected individuals.
